P95HER2 methionine 611 carboxy-terminal fragment is predictive of trastuzumab adjuvant treatment benefit in the FinHer trial

Jeff Sperinde*, Weidong Huang, Aki Vehtari, Ahmed Chenna, Pirkko Liisa Kellokumpu-Lehtinen, John Winslow, Petri Bono, Yolanda S. Lie, Christos J. Petropoulos, Jodi Weidler, Heikki Joensuu

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'P95HER2 methionine 611 carboxy-terminal fragment is predictive of trastuzumab adjuvant treatment benefit in the FinHer trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Neuroscience